Thromboangiitis Obliterans (Buerger's Disease)-Current Practices. - Wikidata - awgldk - TriplyDB

Thromboangiitis Obliterans (Buerger's Disease)-Current Practices.

Thromboangiitis Obliterans (Buerger's Disease)-Current Practices.

http://www.wikidata.org/entity/Q37206152

about

Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy A Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Severe Buerger's Disease ''The association of normal tension glaucoma with Buerger's disease: a case report''.Plasma nitric oxide level is correlated with microvascular functions in the peripheral arterial disease.Thromboangiitis obliterans (Buerger disease)Efficacy of bosentan in patients with refractory thromboangiitis obliterans (Buerger disease): A case series and review of the literature.Therapeutic strategies for cell-based neovascularization in critical limb ischemia Severe gangrene at the glans penis requiring penectomy as the first major complication of Buerger's disease.End stage renal disease caused by thromboangiitis obliterans: a case report.Three cases of dorsal metatarsal artery bypass in patients with Buerger disease

P2860

Q33722293-FB468037-E5F4-43E3-AABF-6903C20F8284 Q33901995-FD07CC93-D168-453E-A3E4-88997777B414 Q34581895-D1BEE95F-A456-4914-BED9-E02216C979A5 Q36226551-60A80ABA-1757-4C70-AB6D-2466EECED3EF Q36250891-BE0BC0FA-0598-4D25-868D-1B0A686BAF76 Q37467859-83EB8F3F-40A5-4251-9956-EF769D0CA68C Q37663453-D5E96722-C041-4AE5-A943-D5E3E0A34E6B Q38356044-3CBCDF49-FBD0-491A-9ED7-E3A36C957A24 Q42643009-1F3DA199-DBA6-497E-9F0C-D2EAC572F382 Q58769758-049C5218-D8C8-458E-BB7F-66B7BF7B46E4

P2860

Thromboangiitis Obliterans (Buerger's Disease)-Current Practices.

http://www.wikidata.org/entity/Q37206152

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Thromboangiitis Obliterans (Buerger's Disease)-Current Practices.

@en

type

label

Thromboangiitis Obliterans (Buerger's Disease)-Current Practices.

@en

prefLabel

Thromboangiitis Obliterans (Buerger's Disease)-Current Practices.

@en

P1433

Q37206152-3BCCBD99-F7BC-4038-A864-8364887CEF20

P1476

Q37206152-6FD2287F-E269-4C51-9B92-13DEA2375F3C

P2093

Q37206152-1E0D7608-8211-4FBC-9B92-4CFD45A6B262

Q37206152-4C66025C-B7D9-46A0-85F0-1AE234163765

P2860

Q37206152-02DC6684-8A0F-4035-96BC-3247ACC3D161

Q37206152-16A35722-D017-4B25-AB08-DF1BF46E630B

Q37206152-180D098F-CEFE-4AC6-8A3D-A4E5DD4B7E13

Q37206152-1A67212F-2C56-4168-9A7D-3F0B29BF052D

Q37206152-1B57834D-952A-4D8A-AB16-602E70BB7E9C

Q37206152-1D1BDDF8-50B0-427F-B49A-F6F81F33525F

Q37206152-1F60A471-DFFE-4CE2-BF81-995CC0B874E7

Q37206152-20024FC2-2F5E-42E7-9699-44CF569C67D1

Q37206152-25461CD5-2529-4561-BA00-DC22B0E467DB

Q37206152-4C36FCA4-303E-4C96-AA1E-EFC3DEBEB79A

P304

Q37206152-96AFD2C3-F729-466B-824D-A2CCB459240E

P31

Q37206152-704858D6-2AA8-48AD-BB0A-467CB926ECBD

P356

Q37206152-1BEE2267-4E2C-4004-BCA4-582E0C6500C7

P478

Q37206152-501601D9-76D6-4C30-9A14-5B16BE35FF8E

P50

Q37206152-A73B78AD-5043-498C-BA01-7BF2EABF71CA

P577

Q37206152-7023EACF-2AC6-4C09-AC4D-3A895F425870

P5875

Q37206152-4270C675-F7D2-4472-8429-39788310320B

P698

Q37206152-75529059-E179-4B0B-B0EF-A97211B0F0AD

P932

Q37206152-3D30C84D-4FD2-4630-A199-34059A1881F2

P356

P1433

International Journal of Inflammation

P1476

Thromboangiitis Obliterans (Buerger's Disease)-Current Practices

@en

P2093

Rahul Tiwari

http://www.w3.org/2001/XMLSchema#string

Vinod Kumar Prabhuswamy

http://www.w3.org/2001/XMLSchema#string

P2860

Rheumatic manifestations in patients with thromboangiitis obliterans (Buerger's disease).

Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).

Thromboangiitis obliterans (Buerger's disease).

Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.

The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease).

The brothers von Winiwarter, Alexander (1848-1917) and Felix (1852-1931), and thromboangiitis obliterans.

Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.

Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan.

Buerger's Disease (Thromboangiitis Obliterans)- Management by Ilizarov's Technique of Horizontal Distraction. A Retrospective Study of 60 Cases.

Ischemic intestinal involvement in a patient with Buerger disease: case report and literature review.

P304

156905

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/156905

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Abhishek Vijayakumar

P577

2013-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257531839

http://www.w3.org/2001/XMLSchema#string

P698

24102033

http://www.w3.org/2001/XMLSchema#string

P932

3786473

http://www.w3.org/2001/XMLSchema#string